Effect of food on the bioavailability of captopril in healthy subjects

SM SINGHVI, DN McKINSTRY… - The journal of …, 1982 - Wiley Online Library
14C‐Captopril was administered as 100‐mg tablets to 12 subjects in a two‐way crossover
study in which subjects were either fasted or were given a standard meal immediately prior …

Estimation of kinetic parameters from a two‐point determination of the drug cumulation factor

TD Bjornsson, DG Shand - Clinical Pharmacology & …, 1979 - Wiley Online Library
A method is described which allows the calculation of kinetic parameters of drugs from two
data points, involving a set of simple algebraic equations. This method is based on …

Three new long‐acting converting‐enzyme inhibitors: relationship between plasma converting‐enzyme activity and response to angiotensin I

J Biollaz, M Burnier, GA Turini… - Clinical …, 1981 - Wiley Online Library
Three new angiotensin converting‐enzyme inhibitors were given orally to 20 men in single
doses ranging from 1.25 to 40 mg. Two of them induced comparable marked inhibition of …

Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors

CI Johnston, B Jackson, R Cubela… - Journal of …, 1986 - journals.lww.com
The increasing number of angiotensin converting enzyme (ACE) inhibitors means that
compounds with different enzyme kinetics, pharmacokinetics, bioavailability, and …

An area function method for calculating the apparent elimination rate constant of a metabolite

H Cheng, WJ Jusko - Journal of pharmacokinetics and biopharmaceutics, 1989 - Springer
A simple method for determination of the apparent elimination rate constant of a metabolite
(km) has been developed. This procedure requires calculation of area intervals under the …

[引用][C] Per cent absorbed versus time plots from metabolite level in blood

E Nelson - Journal of Pharmaceutical Sciences, 1965 - Wiley Online Library
1 WILLIAM N. CHARMAN, SUSAN A. CHARMAN, DONALD C. MONKHOUSE, STEVEN E.
FRISBEE, EARLE A. LOCKHART, STEVEN WEISMAN, GARRET A. FITZGERALD …

Pharmacokinetics of angiotensin converting enzyme inhibitors.

M Burnier, B Waeber, J Nussberger… - British journal of …, 1989 - Wiley Online Library
1. The pharmacokinetics of most ACE inhibitors have been evaluated indirectly by the
measurements of plasma ACE activity and circulating levels of angiotensin I and II. 2 …

Determination of the in Vivo Km and Vmax of a Drug With Tracer Studies

TR Browne, D Greenblatt, JE Evans… - The Journal of …, 1987 - Wiley Online Library
A method is described for determining the in vivo Km and Vmax values for a drug, utilizing a
variant of the Michaelis‐Menten equation and the elimination‐rate constants of tracer doses …

Enzyme kinetics in relation to enzyme inhibitors

KF Tipton - Biochemical Pharmacology, 1973 - Elsevier
A Large number of pharmacologically important compounds have been found to act as
enzyme inhibitors and a kinetic study of the inhibitory process can provide important …

Problems associated with analysis of pharmacokinetic models

WJ Westlake - Journal of Pharmaceutical Sciences, 1971 - Wiley Online Library
When a pharmacokinetic model is fitted to blood levels of a drug, the estimates of the
pharmacokinetic parameters are likely to be subject to considerable error. These errors are …